Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52024XC04646

Oversigt over EU-afgørelser om tilladelse til markedsføring af lægemidler fra 1. juni 2024 til 30. juni 2024 (Offentliggjort i henhold til artikel 13 eller artikel 38 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004 eller Artikel 5 i Europa-Parlamentets og Rådets forordning (EU) 2019/6)

PUB/2024/703

EUT C, C/2024/4646, 31.7.2024, ELI: http://data.europa.eu/eli/C/2024/4646/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

ELI: http://data.europa.eu/eli/C/2024/4646/oj

European flag

Den Europæiske Unions
Tidende

DA

C-udgaven


C/2024/4646

31.7.2024

Oversigt over EU-afgørelser om tilladelse til markedsføring af lægemidler fra 1. juni 2024 til 30. juni 2024

(Offentliggjort i henhold til artikel 13 eller artikel 38 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004  (1) eller Artikel 5 i Europa-Parlamentets og Rådets forordning (EU) 2019/6  (2) )

(C/2024/4646)

Udstedelse af markedsføringstilladelse (artikel 13 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004): Godkendt

Dato for afgørelser

Lægemidlets navn

INN-navn (International Non-Proprietary Name)

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Lægemiddelform

ATC-kode (Anatomical Therapeutic Chemical Code)

Dato for notifikation

3.6.2024

Fluenz

Influenzavaccine (levende svækket, nasal)

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/24/1816

Næsespray, suspension

J07BB03

4.6.2024

17.6.2024

ALTUVOCT

efanesoctocog alfa

Swedish Orphan Biovitrum AB (publ)

112 76 Stockholm, Sverige

EU/1/24/1824

Pulver og solvens til opløsning, injektion

B02BD02

18.6.2024

17.6.2024

Sirturo

bedakilin

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/13/901

Tablet

J04AK05

18.6.2024

17.6.2024

Truqap

capivasertib

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/24/1820

Filmovertrukket tablet

L01EX27

18.6.2024

20.6.2024

FRUZAQLA

fruquintinib

Takeda Pharmaceuticals International AG Ireland Branch

Block 2 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, D02 HW68, Ireland

EU/1/24/1827

Kapsler, hårde

L01EK

25.6.2024

20.6.2024

Tofidence

tocilizumab

Biogen Netherlands B.V.

Prins Mauritslaan 13, 1171 LP Badhoevedorp, Nederland

EU/1/24/1825

Koncentrat till infusionsvaeske, opløsning

L04AC07

21.6.2024

20.6.2024

Wezenla

Ustekinumab

Amgen Technology (Ireland) UC

Pottery Road, Dun Laoghaire, Co. Dublin, Ireland

EU/1/24/1823

Injektionsvæske, opløsning i en fyldt injektionssprøjte

Injektionsvœske, opløsning

Koncentrat till infusionsvaeske, opløsning

L04AC05

22.6.2024

27.6.2024

Eribulin Baxter

eribulin

Baxter Holding B.V.

Kobaltweg 49, 3542 CE Utrecht, Nederland

EU/1/24/1819

Injektionsvœske, opløsning

L01XX41

1.7.2024

27.6.2024

JERAYGO

aprocitentan

Idorsia Pharmaceuticals Deutschland GmbH

Marie-Curie-Strasse 8, 79539 Loerrach, Deutschland

EU/1/24/1818

Filmovertrukket tablet

C02KN01

28.6.2024

27.6.2024

Obgemsa

Vibegron

PIERRE FABRE MEDICAMENT

Les Cauquillous, 81500 Lavaur, France

EU/1/24/1822

Filmovertrukket tablet

G04BD15

28.6.2024

27.6.2024

Rybrevant

amivantamab

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/21/1594

Koncentrat till infusionsvaeske, opløsning

L01FX18

28.6.2024

28.6.2024

IXCHIQ

Chikungunya-vaccine (levende)

Valneva Austria GmbH

Campus Vienna Biocenter 3, 1030 Wien, Österreich

EU/1/24/1828

Pulver og solvens til opløsning, injektion

Pending

28.6.2024

Ændring af markedsføringstilladelse (artikel 13 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004): Godkendt

Dato for afgørelser

Lægemidlets navn

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Dato for notifikation

6.6.2024

Alecensa

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/16/1169

7.6.2024

6.6.2024

Cinqaero

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/16/1125

11.6.2024

6.6.2024

Efavirenz/Emtricitabine/Tenofovir disoproxil Krka

KRKA d d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/17/1263

17.6.2024

6.6.2024

Fasenra

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/17/1252

7.6.2024

6.6.2024

Lymphoseek

Navidea Biopharmaceuticals Europe Ltd.

Kilminion South, Ballinroad, Dungarvan, Co. Waterford, X35 WP70, Ireland

EU/1/14/955

7.6.2024

6.6.2024

Pedmarqsi

Norgine B.V.

Antonio Vivaldistraat 150, 1083 HP Amsterdam, Nederland

EU/1/23/1734

7.6.2024

6.6.2024

Ritonavir Mylan

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/17/1242

7.6.2024

6.6.2024

Suliqua

Sanofi Winthrop Industrie

82 avenue Raspail, 94250 Gentilly, France

EU/1/16/1157

7.6.2024

6.6.2024

Sunlenca

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/22/1671

7.6.2024

6.6.2024

Synflorix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, 1330 Rixensart, Belgique

EU/1/09/508

10.6.2024

6.6.2024

Tepmetko

Merck Europe B.V.

Gustav Mahlerplein 102, 1082 MA Amsterdam, Nederland

EU/1/21/1596

10.6.2024

6.6.2024

Twynsta

Boehringer Ingelheim International GmbH

Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

EU/1/10/648

17.6.2024

6.6.2024

Veltassa

Vifor Fresenius Medical Care Renal Pharma France

100-101 terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris la Défense Cedex, France

EU/1/17/1179

7.6.2024

10.6.2024

AMGLIDIA

AMMTeK

8 rue campagne première, 75014 Paris, France

EU/1/18/1279

12.6.2024

10.6.2024

Ozempic

Novo Nordisk A/S

Novo Allé, 2880 Bagsvaerd, Danmark

EU/1/17/1251

11.6.2024

10.6.2024

Respreeza

CSL Behring GmbH

Emil-von-Behring-Straße 76, 35041 Marburg, Deutschland

EU/1/15/1006

26.6.2024

10.6.2024

Wegovy

Novo Nordisk A/S

Novo Allé, 2880 Bagsvaerd, Danmark

EU/1/21/1608

11.6.2024

13.6.2024

Atazanavir Viatris

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/16/1091

14.6.2024

13.6.2024

Darunavir Viatris

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/16/1140

14.6.2024

13.6.2024

Inbrija

Acorda Therapeutics Ireland Limited

10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland

EU/1/19/1390

14.6.2024

13.6.2024

Lopinavir/Ritonavir Viatris

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/15/1067

14.6.2024

13.6.2024

Ritonavir Viatris

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/17/1242

14.6.2024

13.6.2024

TALVEY

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/23/1748

14.6.2024

13.6.2024

TECVAYLI

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/22/1675

14.6.2024

13.6.2024

Telmisartan Actavis

Actavis Group PTC ehf.

Dalshraun 1, 220 Hafnarfjörður, Íceland

EU/1/10/639

14.6.2024

17.6.2024

Eviplera

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/11/737

18.6.2024

17.6.2024

Forxiga

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/12/795

18.6.2024

17.6.2024

Galafold

Amicus Therapeutics Europe Limited

Block 1, Blanchardstown Corporate Park, Ballycoolin Road, Blanchardstown, Dublin D15 AKK1, Ireland

EU/1/15/1082

19.6.2024

17.6.2024

Giotrif

Boehringer Ingelheim International GmbH

Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

EU/1/13/879

18.6.2024

17.6.2024

Givlaari

Alnylam Netherlands B.V.

Antonio Vivaldistraat 150, 1083 HP Amsterdam, Nederland

EU/1/20/1428

18.6.2024

17.6.2024

Kinpeygo

STADA Arzneimittel AG

Stadastraße 2-18, 61118 Bad Vilbel, Deutschland

EU/1/22/1657

20.6.2024

17.6.2024

Mektovi

Pierre Fabre Médicament

Les Cauquillous, 81500 Lavaur, France

EU/1/18/1315

18.6.2024

17.6.2024

Pioglitazon Actavis

Actavis Group PTC ehf.

Dalshraun 1, 220 Hafnarfjörður, Íceland

EU/1/12/755

18.6.2024

17.6.2024

Rasagiline Viatris

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/16/1090

18.6.2024

17.6.2024

Renagel

Sanofi B.V.

Paasheuvelweg 25, 1105 BP Amsterdam, Nederland

EU/1/99/123

19.6.2024

17.6.2024

Verzenios

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/18/1307

18.6.2024

17.6.2024

Vfend

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

EU/1/02/212

18.6.2024

17.6.2024

Xultophy

Novo Nordisk A/S

Novo Allé, 2880 Bagsvaerd, Danmark

EU/1/14/947

19.6.2024

17.6.2024

Yentreve

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/04/280

18.6.2024

17.6.2024

Zometa

Phoenix Labs Unlimited Company

Suite 12, Bunkilla Plaza, Bracetown Business Park, Clonee, County Meath, Ireland

EU/1/01/176

18.6.2024

20.6.2024

Abecma

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

EU/1/21/1539

26.6.2024

20.6.2024

Abiraterone Mylan

Mylan Ireland Limited

Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

EU/1/21/1571

21.6.2024

20.6.2024

Bridion

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/08/466

24.6.2024

20.6.2024

Cinacalcet Accordpharma

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

EU/1/20/1429

21.6.2024

20.6.2024

CONTROLOC Control

Takeda GmbH

Byk-Gulden-Straße 2, 78467 Konstanz, Deutschland

EU/1/09/515

25.6.2024

20.6.2024

Cymbalta

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/04/296

25.6.2024

20.6.2024

Duloxetin Lilly

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/14/972

24.6.2024

20.6.2024

Ifirmacombi

KRKA d d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/11/673

26.6.2024

20.6.2024

Kesimpta

Novartis Ireland Limited

Vista Building, Elm Park, Merrion Road, Ballsbridge, Dublin 4, Ireland

EU/1/21/1532

21.6.2024

20.6.2024

Livmarli

Mirum Pharmaceuticals International B.V.

Kingsfordweg 151, 1043 GR Amsterdam, Noord-Holland, Nederland

EU/1/22/1704

21.6.2024

20.6.2024

Ocrevus

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/17/1231

21.6.2024

20.6.2024

PANTOZOL Control

Takeda GmbH

Byk-Gulden-Straße 2, 78467 Konstanz, Deutschland

EU/1/09/517

25.6.2024

20.6.2024

SOMAC Control

Takeda GmbH

Byk-Gulden-Straße 2, 78467 Konstanz, Deutschland

EU/1/09/516

25.6.2024

20.6.2024

Spravato

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/19/1410

24.6.2024

20.6.2024

Tivicay

ViiV Healthcare BV

Van Asch van Wijckstraat 55H, 3811 LP Amersfoort, Nederland

EU/1/13/892

21.6.2024

20.6.2024

TOBI Podhaler

Viatris Healthcare Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland

EU/1/10/652

21.6.2024

20.6.2024

Vabysmo

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/22/1683

21.6.2024

20.6.2024

Voriconazole Accord

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

EU/1/13/835

21.6.2024

20.6.2024

Voriconazole Hikma

Hikma Farmacêutica (Portugal), S.A.

Estrada do Rio da Mó n.o 8, 8A e 8B, Fervença, 2705-906 Terrugem SNT, Portugal

EU/1/15/1004

28.6.2024

20.6.2024

Voxzogo

BioMarin International Limited

Shanbally, Ringaskiddy, County Cork, P43 R298, Ireland

EU/1/21/1577

24.6.2024

20.6.2024

Xaluprine

Nova Laboratories Ireland Limited

3rd Floor, Ulysses House, Foley Street, Dublin 1, Ireland

EU/1/11/727

21.6.2024

20.6.2024

Xerava

PAION Deutschland GmbH

Heussstraße 25, 52078 Aachen, Deutschland

EU/1/18/1312

24.6.2024

20.6.2024

Xtandi

Astellas Pharma Europe B.V.

Sylviusweg 62, 2333 BE Leiden, Nederland

EU/1/13/846

21.6.2024

20.6.2024

Zabdeno

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/20/1444

21.6.2024

20.6.2024

Zyclara

Viatris Healthcare Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland

EU/1/12/783

24.6.2024

20.6.2024

Zydelig

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/14/938

21.6.2024

20.6.2024

Оlanzapin Mylan

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/08/475

21.6.2024

27.6.2024

Byetta

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/06/362

28.6.2024

27.6.2024

Levetiracetam Accord

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

EU/1/11/712

28.6.2024

27.6.2024

Mepact

Takeda France SAS

112 avenue Kléber, 75116 Paris, France

EU/1/08/502

2.7.2024

27.6.2024

Nucala

GlaxoSmithKline Trading Services Limited

Riverwalk 12, Citywest Business Campus, Dublin 24, Ireland

EU/1/15/1043

1.7.2024

27.6.2024

Rozlytrek

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/20/1460

28.6.2024

27.6.2024

Stribild

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/13/830

28.6.2024

27.6.2024

Tavneos

Vifor Fresenius Medical Care Renal Pharma France

100-101 terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris la Défense Cedex, France

EU/1/21/1605

28.6.2024

27.6.2024

Vokanamet

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/14/918

28.6.2024

27.6.2024

Xospata

Astellas Pharma Europe B.V.

Sylviusweg 62, 2333 BE Leiden, Nederland

EU/1/19/1399

28.6.2024

27.6.2024

Zoledronsyre medac

medac Gesellschaft für klinische Spezialpräparate mbH

Theaterstraße 6, 22880 Wedel, Deutschland

EU/1/12/779

28.6.2024

28.6.2024

Cabazitaxel Accord

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

EU/1/20/1448

1.7.2024

28.6.2024

CRYSVITA

Kyowa Kirin Holdings B.V.

Bloemlaan 2, 2132 NP Hoofddorp, Nederland

EU/1/17/1262

2.7.2024

28.6.2024

Dovprela

Mylan IRE Healthcare Limited

Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

EU/1/20/1437

1.7.2024

28.6.2024

Dupixent

Sanofi Winthrop Industrie

82 avenue Raspail, 94250 Gentilly, France

EU/1/17/1229

1.7.2024

28.6.2024

Edistride

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/15/1052

1.7.2024

28.6.2024

Emtricitabine/Tenofovir disoproxil Mylan

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/16/1133

1.7.2024

28.6.2024

Invokana

Janssen-Cilag International NV

Turnhoutseweg 30, 2340 Beerse, België

EU/1/13/884

1.7.2024

28.6.2024

Isturisa

Recordati Rare Diseases

Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France

EU/1/19/1407

1.7.2024

28.6.2024

Kineret

Swedish Orphan Biovitrum AB (publ)

112 76 Stockholm, Sverige

EU/1/02/203

9.7.2024

28.6.2024

Livmarli

Mirum Pharmaceuticals International B.V.

Kingsfordweg 151, 1043 GR Amsterdam, Noord-Holland, Nederland

EU/1/22/1704

1.7.2024

28.6.2024

Matever

Pharmathen S.A.

6 Dervenakion, 15351 Pallini Attiki, Ελλάδα

EU/1/11/711

3.7.2024

28.6.2024

Relvar Ellipta

GlaxoSmithKline (Ireland) Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/13/886

1.7.2024

28.6.2024

Revinty Ellipta

GlaxoSmithKline (Ireland) Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/14/929

1.7.2024

28.6.2024

Rotarix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, 1330 Rixensart, Belgique

EU/1/05/330

2.7.2024

28.6.2024

Supemtek

Sanofi Pasteur

14 Espace Henry Vallée, 69007 Lyon, France

EU/1/20/1484

1.7.2024

28.6.2024

TAGRISSO

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/16/1086

1.7.2024

28.6.2024

Zonisamide Mylan

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/16/1093

1.7.2024

Tilbagekaldelse af markedsføringstilladelse (artikel 13 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004)

Dato for afgørelser

Lægemidlets navn

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Dato for notifikation

6.6.2024

Nityr

Cycle Pharmaceuticals (Europe) Ltd

70 Sir John Rogerson's Quay, Dublin 2, D02 R296, Ireland

EU/1/18/1290

7.6.2024

10.6.2024

Lymphoseek

Navidea Biopharmaceuticals Europe Ltd.

Kilminion South, Ballinroad, Dungarvan, Co. Waterford, X35 WP70, Ireland

EU/1/14/955

13.6.2024

28.6.2024

Pemetrexed Krka

KRKA, d.d.

Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/18/1283

4.7.2024

Ændring af markedsføringstilladelse (artikel 38 i Europa-Parlamentets og Rådets forordning (EF) nr. 726/2004; Artikel 5 i Europa-Parlamentets og Rådets forordning (EU) 2019/6): Godkendt

Dato for afgørelser

Lægemidlets navn

Indehaver af markedsføringstilladelsen

Nummer i EF-registret

Dato for notifikation

6.6.2024

Arti-Cell Forte

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/18/228

7.6.2024

6.6.2024

Coxevac

Ceva Santé Animale

10 avenue de La Ballastière, 33500 Libourne, France

EU/2/10/110

7.6.2024

6.6.2024

Tessie

Orion Corporation

Orionintie 1, 02200 Espoo, Suomi

EU/2/21/276

7.6.2024

13.6.2024

Eurican Herpes 205

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/01/029

17.6.2024

13.6.2024

Versican Plus Pi

Zoetis Belgium

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/14/168

18.6.2024

Alle interesserede kan ved henvendelse på nedenstående adresse få tilsendt den offentlige evalueringsrapport om de pågældende lægemidler og de afgørelser, der er truffet vedrørende disse:

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS


(1)   EUT L 136 af 30.4.2004, s. 1, ELI: https://data.europa.eu/eli/reg/2004/726/oj.

(2)   EUT L 4 af 7.1.2019, s. 43, ELI: https://data.europa.eu/eli/reg/2019/6/oj.


ELI: http://data.europa.eu/eli/C/2024/4646/oj

ISSN 1977-0871 (electronic edition)


Top